Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New upgrade: Journal your trades with more detail

AtaiBeckley N.V.

Contributing Author

Recent Articles by AtaiBeckley N.V.

Mar-03	AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression ATAI GlobeNewswire
Feb-26	AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder ATAI -14.06% GlobeNewswire
Feb-20	AtaiBeckley To Host Virtual Investor Day on March 6, 2026 ATAI GlobeNewswire
Feb-19	AtaiBeckley Appoints Michael Faerm as Chief Financial Officer ATAI GlobeNewswire
Feb-17	AtaiBeckley To Participate in Upcoming Investor Conferences ATAI +6.44% GlobeNewswire
Jan-16	AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation ATAI GlobeNewswire
Jan-08	AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference ATAI GlobeNewswire
Dec-30	AtaiBeckley Completes Redomiciliation to the United States ATAI GlobeNewswire
Dec-30	AtaiBeckley Completes Redomiciliation to the United States ATAI GlobeNewswire
Dec-23	AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) ATAI GlobeNewswire
Dec-11	AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio ATAI GlobeNewswire
Nov-13	AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London ATAI GlobeNewswire
Nov-12	AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights ATAI GlobeNewswire
Nov-10	AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression ATAI GlobeNewswire
Nov-05	atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies ATAI -15.15% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)